| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $133.9M | +14.2% |
| Cost of Revenue | $49.7M | +1.2% |
| Gross Profit | $84.3M | +23.5% |
| R&D Expense | $2.1M | -11.9% |
| SG&A Expense | $29.4M | +2.4% |
| Operating Income | $7.3M | +160.3% |
| Interest Expense | $3.7M | -11.8% |
| Pre-tax Income | $7.0M | +143.1% |
| Income Tax | $2.0M | +984.5% |
| Net Income | $5.0M | +130.2% |
| EPS (Basic) | $0.04 | +133.3% |
| EPS (Diluted) | $0.03 | +125.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $17.1M | +175.1% |
| Accounts Receivable | $17.8M | -13.8% |
| Inventory | $30.3M | -21.7% |
| Current Assets | $78.2M | +16.6% |
| Total Assets | $94.1M | +0.3% |
| Current Liabilities | $29.5M | +3.2% |
| Long-term Debt | $11.0M | -50.0% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $12.5M | +205.5% |
| Capital Expenditures | $2.4M | -42.1% |
| Investing Cash Flow | $7.9M | +311.8% |
| Financing Cash Flow | -$9.6M | -159.5% |
| Free Cash Flow | $10.2M | +163.5% |
| $43.2M |
| -15.1% |
| Stockholders' Equity | $51.0M | +18.6% |